Comments on: “Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens” (Monk BJ, Sill MW, Hanjani P, Edwards R, Rotmensch J, De Geest K, et al. Gynecol Oncol. 2011 Mar;120(3):459–63)

✍ Scribed by Michael W. Sill; Bradley J. Monk

• Book ID: 113963260
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 62 KB
• Volume: 122
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2011.05.026